A THREE-MONTH, PROSPECTIVE, OPEN-LABEL, TWO COHORT STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF EC-MPS IN COMBINATION WITH CYCLOSPORINE OR TACROLIMUS IN RENAL TRANSPLANT RECIPIENTS WITH GI INTOLERANCE. | Publicación